journal article·2014-02

Indole conjugated silica and magnetic nanoparticles as inhibitors of HIF

Qiu-Yun Chen, Zhi-Wei Wang, Xia Yang, Li Wang

Publisher page

Abstract

Multifunctional silica nano-vehicles (SiO2@indol-IL) and magnetic nanoparticles (Fe3O4@indol-IL) were constructed through the Schiff bases condensation of indole-3-carboxaldehyde and 4-acetyl-N-allyl pyridinium chloride (ILs) with the amine groups of silica and magnetic nanoparticles. SiO2@indol-IL can inhibit the proliferation of HepG-2 cells in 48 h. Fe3O4@indol-IL can mimic the function of catalase to disproportionate H2O2 to O2, and has obvious effect on the proliferation of HepG-2 cells in 72 h. Moreover, the two nanoparticles show some inhibition on the expression of hypoxia inducible factor (HIF-1α), glucose transporter (GLUT1) and the production of lactate in HepG-2 cells. Therefore, we deduced that indole conjugated silica and magnetic nanparticles could be used as inhibitors of HIF-1α or GLUT1.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Nanoplatforms for cancer theranostics · Metal-Organic Frameworks: Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (19)

Show source-provided references
1. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy10.1016/j.tips.2012.01.005 ↗
2. The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?
3. Hypoxia-inducible factors and their roles in energy metabolism10.1007/s12185-012-1069-y ↗
4. Effects of hypoxia and HIFs on cancer metabolism10.1007/s12185-012-1070-5 ↗
5. Glycolysis inhibition for anticancer treatment10.1038/sj.onc.1209597 ↗
6. Allosteric inhibition of hypoxia inducible factor-2 with small molecules10.1038/nchembio.1185 ↗
7. Cancer genes and the pathways they control10.1038/nm1087 ↗
8. The Warburg effect and mitochondrial stability in cancer cells10.1016/j.mam.2009.12.004 ↗
9. Targeting cancer metabolism: a therapeutic window opens
10. Synthesis, characterization and biological activity of Schiff base analogues of indole-3-carboxaldehyde10.1016/j.ejmech.2007.03.022 ↗
11. Synthesis and characterization of some new complexes of Cu(II), Ni(II) and V(IV) with Schiff base derived from indole-3-carboxaldehyde. Biological activity on prokaryotes and eukaryotes10.1016/j.ejmech.2012.03.046 ↗
12. Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation10.1021/jm201734r ↗
13. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs10.1021/nn9015345 ↗
14. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging10.1016/j.colsurfb.2013.04.009 ↗
15. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells10.1016/j.colsurfb.2013.03.037 ↗
16. An ionic liquid-modified nano-vehicle to construct nano-models of catalase to target mitochondria
17. Synthesis, characterization, cell imaging and anti-tumor activity of multifunctional nanoparticles10.1016/j.saa.2012.05.033 ↗
18. High glucose concentrations attenuate hypoxia-inducible factor-1α expression and signaling in non-tumor cells10.1016/j.yexcr.2010.02.019 ↗
19. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells